Long-term colorectal-cancer incidence and mortality after lower endoscopy.

PubWeight™: 7.72‹?› | Rank: Top 0.1%

🔗 View Article (PMC 3840160)

Published in N Engl J Med on September 19, 2013

Authors

Reiko Nishihara1, Kana Wu, Paul Lochhead, Teppei Morikawa, Xiaoyun Liao, Zhi Rong Qian, Kentaro Inamura, Sun A Kim, Aya Kuchiba, Mai Yamauchi, Yu Imamura, Walter C Willett, Bernard A Rosner, Charles S Fuchs, Edward Giovannucci, Shuji Ogino, Andrew T Chan

Author Affiliations

1: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

Associated clinical trials:

AmplifEYE Colonoscopy vs Standard Colonoscopy | NCT03814369

Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study) (POLIPEVA) | NCT04636619

Articles citing this

(truncated to the top 100)

Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. JAMA Oncol (2016) 4.90

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19

Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology (2014) 3.03

Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91

Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2014) 2.27

A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology (2015) 2.14

Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ (2014) 1.95

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology (2016) 1.89

Quantification of Adequate Bowel Preparation for Screening or Surveillance Colonoscopy in Men. Gastroenterology (2015) 1.79

Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ (2015) 1.51

Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc (2015) 1.51

Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut (2014) 1.51

Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46

Non-physician endoscopists: A systematic review. World J Gastroenterol (2015) 1.44

Patient Non-adherence and Cancellations Are Higher for Screening Colonoscopy Compared with Surveillance Colonoscopy. Dig Dis Sci (2015) 1.41

Suboptimal Bowel Preparation Significantly Impairs Colonoscopic Detection of Non-polypoid Colorectal Neoplasms. Dig Dis Sci (2015) 1.41

Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology (2015) 1.40

Colorectal cancer screening: will non-invasive procedures triumph? Genome Med (2014) 1.40

Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ (2017) 1.38

Low rate of large polyps (>9 mm) within 10 years after an adequate baseline colonoscopy with no polyps. Gastroenterology (2014) 1.23

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut (2015) 1.17

Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol (2015) 1.16

Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intest Res (2014) 1.15

Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci (2014) 1.15

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol (2015) 1.12

Lower endoscopy and prevention of colon cancer. Gastroenterology (2014) 1.12

Colorectal-cancer incidence and mortality after screening. N Engl J Med (2013) 1.09

Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci (2015) 1.09

Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol (2016) 1.09

Early-onset colorectal cancer: a sporadic or inherited disease? World J Gastroenterol (2014) 1.09

Colorectal cancer. Nat Rev Dis Prim (2015) 1.07

Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf) (2015) 1.05

Methylation of cell-free circulating DNA in the diagnosis of cancer. Front Mol Biosci (2015) 1.04

Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One (2014) 1.03

Associations of census-tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States. J Cancer Epidemiol (2014) 1.01

Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Br J Cancer (2015) 1.00

Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med (2016) 1.00

Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol (2014) 0.99

Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99

Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol (2014) 0.98

Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice. Int J Cancer (2014) 0.97

Yield of repeat forward-view examination of the right side of the colon in screening and surveillance colonoscopy. Gastrointest Endosc (2016) 0.97

The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci (2015) 0.96

Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96

Higher adenoma detection rates with endocuff-assisted colonoscopy - a randomized controlled multicenter trial. PLoS One (2014) 0.95

Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci (2014) 0.95

Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn (2015) 0.94

Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94

Yield of screening colonoscopy in renal transplant candidates. Can J Gastroenterol Hepatol (2015) 0.93

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA (2015) 0.92

Molecular markers for colorectal cancer screening. Gut (2015) 0.92

Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? Gastrointest Endosc (2015) 0.92

Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci (2014) 0.91

Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. J Natl Cancer Inst (2015) 0.89

Colorectal-cancer screening--coming of age. N Engl J Med (2013) 0.89

Practice and documentation of performance of colonoscopy in a central Canadian health region. Can J Gastroenterol Hepatol (2014) 0.89

Diagnostic and therapeutic applications of water-immersion colonoscopy. World J Gastroenterol (2015) 0.88

Interval Colorectal Cancer After Colonoscopy: Exploring Explanations and Solutions. Am J Gastroenterol (2015) 0.88

Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study. Ann Intern Med (2016) 0.87

Age-specific prevalence of serrated lesions and their subtypes by screening colonoscopy: a retrospective study. BMC Gastroenterol (2014) 0.86

Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol (2016) 0.86

A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. Am J Epidemiol (2015) 0.85

Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer. Gastrointest Endosc (2015) 0.85

External Validation of the Endoscopic Features of Sessile Serrated Adenomas in Expert and Trainee Colonoscopists. Clin Endosc (2016) 0.85

The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy. Sci Rep (2015) 0.84

The Impact of Colonoscopy Quality Control Table on Adenoma Detection Rates. Gastroenterol Res Pract (2016) 0.84

Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc (2015) 0.84

Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev (2014) 0.84

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut (2016) 0.83

New era of colorectal cancer screening. World J Gastrointest Endosc (2016) 0.83

Advanced endoscopic imaging to improve adenoma detection. World J Gastrointest Endosc (2015) 0.83

A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity. Ann Surg (2016) 0.83

Predictors of Suboptimal Bowel Preparation Using 3-l of Polyethylene Glycol for an Outpatient Colonoscopy: A Prospective Observational Study. Dig Dis Sci (2016) 0.82

Establishing a biological profile for interval colorectal cancers. Dig Dis Sci (2014) 0.82

Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. Am J Clin Nutr (2014) 0.81

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep (2016) 0.81

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer (2016) 0.81

Characterizing the prevalence of chromosome instability in interval colorectal cancer. Neoplasia (2015) 0.81

Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget (2016) 0.81

Diagnostics and Epidemiology of Colorectal Cancer. Visc Med (2016) 0.81

Physician report cards and implementing standards of practice are both significantly associated with improved screening colonoscopy quality. Am J Gastroenterol (2015) 0.81

Malignant Duodeno-Colic Fistula: A Rare Complication of Colorectal Cancer. J Clin Diagn Res (2015) 0.81

Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer. World J Gastrointest Oncol (2016) 0.80

Colorectal-cancer incidence and mortality after screening. N Engl J Med (2013) 0.80

Electrolyte changes after bowel preparation for colonoscopy: A randomized controlled multicenter trial. World J Gastroenterol (2015) 0.79

Epidemiological Trends in Colorectal Cancer in China: An Ecological Study. Dig Dis Sci (2016) 0.79

Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study. Gastroenterology (2016) 0.79

Smoking status informs about the risk of advanced serrated polyps in a screening population. Endosc Int Open (2015) 0.79

High-quality Bowel Preparation Is Required for Detection of Sessile Serrated Polyps. Clin Gastroenterol Hepatol (2016) 0.79

Clinicopathological characteristics of newly diagnosed colorectal cancers in community gastroenterology practice. Intest Res (2014) 0.79

Differences between husbands and wives in colonoscopy use: Results from a national sample of married couples. Prev Med (2016) 0.79

Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol (2016) 0.79

Outcomes of endoscopic treatment of second recurrences of large nonpedunculated colorectal adenomas. Surg Endosc (2015) 0.78

Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions. Am J Gastroenterol (2016) 0.78

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol (2016) 0.78

How does the serrated polyp pathway alter CRC screening and surveillance? Dig Dis Sci (2015) 0.78

Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol (2016) 0.78

The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism. J Pharmacol Exp Ther (2015) 0.78

Genomic era diagnosis and management of hereditary and sporadic colon cancer. World J Clin Oncol (2014) 0.78

Articles cited by this

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16

Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48

Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26

Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA (2006) 6.26

Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med (2008) 4.55

Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37

Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22

Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology (2012) 4.13

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75

Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74

Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ (2008) 3.58

Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control (2007) 3.49

Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol (2008) 2.91

Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77

CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol (2009) 2.17

Interval cancers after negative colonoscopy: population-based case-control study. Gut (2011) 1.97

The capsule and colorectal-cancer screening--the crux of the matter. N Engl J Med (2009) 1.95

Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology (2008) 1.60

Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol (2011) 1.43

Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut (2011) 1.42

Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res (2013) 1.42

Impact of smoking and smoking cessation on health-related quality of life in women in the Nurses' Health Study. Qual Life Res (2008) 1.30

Risk of colorectal cancer after detection and removal of adenomas at colonoscopy: population-based case-control study. J Clin Oncol (2012) 1.28

Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst (2012) 1.24

Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol (2012) 1.21

Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol (2012) 1.02

Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer (2009) 1.01

Why you should care about screening flexible sigmoidoscopy. N Engl J Med (2012) 0.99

Is KRAS mutation associated with interval colorectal cancers? Dig Dis Sci (2011) 0.96

Articles by these authors

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature (2012) 10.39

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res (2009) 6.10

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. Clin Cancer Res (2008) 6.03

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res (2008) 5.18

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med (2003) 4.40

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst (2013) 4.37

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol (2006) 4.27

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24